Do Nektar Therapeutics (NASDAQ: NKTR) Fit In A Value Investing Philosophy?
Currently, there are 184.46M common shares owned by the public and among those 177.74M shares have been available to trade. The company’s stock has a 5-day price change of -13.46% and -49.64% over the past three months. NKTR shares are trading -24.73% year to date (YTD), with the 12-month market performance up to 4.48% higher. […]
Nektar Therapeutics (NKTR): Insights At A Glance
Nektar Therapeutics (NKTR) concluded trading on Wednesday at a closing price of $1.02, with 6.09 million shares of worth about $6.22 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -28.17% during that period and on December 04, 2024 the price saw a loss […]
